High levels of ether phospholipids were found in rat platelets. Alkylacyl compounds constituted 18 and 29% of glycerophosphocholine (GPC) and glycerophosphoethanolamine (GPE). Alkenylacyl compounds, not detected in GPC, represented 40% of GPE. Arachidonate comprised 60%, 42% and 26% of the acyl residues in the sn-2 position of alkenylacyl-GPE, alkylacyl-GPE and alkylacyl-GPC respectively. Based on all arachidonate being linked to the sn-2 position of the diacyl species, the arachidonate level was 47% in diacyl-GPE and 30% in diacyl-GPC. The incorporation and metabolic fate of arachidonate in various phospholipid classes of resting platelets was examined. Arachidonate was essentially recovered in the diacyl phospholipids and very poorly in alkylacyl-and alkenylacyl-GPE and GPC after 30 min incubation in the presence of ['4C]arachidonic acid. Upon reincubation of the platelets after removal of free arachidonate, the radioactivity was gradually lost from diacyl-GPC. Concomitantly, the radioactivities in alkylacyl-GPC, alkylacyl-GPE, alkenylacyl-GPE and to a lower extent in diacyl-GPE were increased. Labelling of glycerophosphoinositol was not changed. This labelling transfer was linear up to 5-6 h, except for alkylacyl-GPC; then labelling remained constant. These data strongly suggest that free arachidonate incorporation through the Lands pathway occurs only for diacyl species and that arachidonate incorporation into the ether phospholipids is achieved by exchange from diacyl-GPC. Based on specific activities related to phosphorus content, the arachidonate incorporation rates into diacyl-GPE and diacyl-GPC were approximately equivalent. The very large differences between specific radioactivities related to arachidonate observed at the starting reincubation time were strongly attenuated when labelling equilibrium was reached. The turnover rate by this exchange pathway was higher in alkylacyl-GPC than in alkyl-and alkenylacyl-GPE. This finding agrees with the selectivity for arachidonate observed in the acylation of PAF-acether in human neutrophils [Chilton, O'Flaherty, Ellis, Swendsen & Wykle (1983) J. Biol. Chem. 258, 7268-7271].
Discrepancies between platelet phospholipid arachidonate content and [14C]arachidonic acid incorporation into platelet phospholipids have been recognized for a long time (Cohen & Derksen, 1969; Bills et al., 1977) . Alkenylacyl-GPE, which contains about 60% of arachidonate (Cohen & Derksen, 1969) , was particularly poorly labelled. Radioactive arachidonate transfer from platelet phospholipids to alkenyl-GPE was observed when Abbreviations used: GPC, glycero-3-phosphocholine; GPE, glycero-3-phosphoethanolamine; GPI, glycero-3-phosphoinositol; GPS, glycero-3-phosphoserine; GPL, glycerophospholipid; PAF, platelet-activating factor. platelets were stimulated with thrombin (Rittenhouse-Simmons et al., 1977) or ionophore (Vargaftig et al., 1980) . A possible arachidonyl exchange into ether phospholipids was also indicated by studies on rat testicular tissues In a previous study (Colard et al., 1984) we have demonstrated a CoA-mediated specific arachidonyl transfer from prelabelled platelet phospholipids to various added lysophospholipids in rat platelet homogenates. Kramer & Deykin (1983) also observed an arachidonyl transfer from GPC to alkenyl-GPE in human platelet homogenates. As this exchange mechanism could explain the arachidonate enrichment of certain phospholipids, we Vol. 222 investigated arachidonate movements in resting intact platelets and found a transfer from GPC to GPE.
High levels of alkylacyl-GPC and -GPE as well as alkenylacyl-GPC and -GPE were recently found in rabbit (Sugiura et al., 1983) and human (Mueller et al., 1983) platelets. Whereas alkenylacyl compounds are easily dissociated from the related diacyl phospholipids by acidic hydrolysis, it is more difficult to obtain the alkylacyl compounds free from the diacyl compounds. These difficulties have impeded studies on arachidonate turnover. However, considerable interest has been focused on alkylacyl-GPC, since the structure of PAFacether has been shown to be 1-alkyl-2-acetyl-GPC (Demopoulos et al. 1979; Benveniste et al., 1979) .
PAF-acether would be synthesized from alkylacyl-GPC by phospholipase A2 hydrolysis followed by an acetylation (Wykle et al., 1980; Ninio et al., 1982; Mueller et al., 1982) . Conversely, PAFacether inactivation could occur in platelets and neutrophils through deacetylatlon followed by acylation into alkylacyl-GPC (Chilton et al., 1982; Touqui et al., 1983; Pieroni & Hanahan, 1983) . In this inactivating acylation reaction, a selectivity for arachidonate was observed in human neutrophils (Chilton et al., 1983) It was, therefore, of interest to investigate arachidonate changes in alkenylacyl and diacyl, as well as in alkylacyl, phospholipids. Using a new method described by El Tamer et al. (1984) for complete ether phospholipid analysis, we found that a long-term arachidonyl transfer from diacyl-GPC to alkylacyl-GPC, alkylacyl-GPE, alkenylacyl-GPE and to a lesser extent diacyl-GPE occurred in resting rat platelets.
Materials and methods
Guinea pig pancreas phospholipase A1 was a gift from Dr. J. Fauvel, who identified and purified this enzyme (Fauvel et al., 1981) . The fraction used was the cationic lipase I. The enzyme (250i.u./ml) was stored at -20°C in 50mM-Tris/HCl buffer (pH9.0) containing 50% (v/v) Diagne et al. (1984) . In practice, lipid extract corresponding to 1 x 109 platelets was dried under N2, 1 ml of 0.2M-Tris/HCl, pH8.0, containing 2.4mM-sodium deoxycholate was added and this mixture was sonicated twice for i5s. Phospholipase A1 (0.5 i.u.) was added and the mixture was incubated at 37°C for 60min. The reaction was stopped and extracted by 1984 the method of Folch et al. (1957) . The lipid extract was dried, then spotted onto a t.l.c. plate and developed for 50min in the solvent system chloroform/methanol/acetic acid/water (180 :108 :11:11, by vol.). After drying, the plate was subjected to HCI fumes for 10min and left to evaporate for at least 1 h before developing in a second direction with chloroform/methanol/14M-NH3/water (180:108 :11:11, by vol.). The various phospholipids were visualized by exposure to iodine vapour or by autoradiography. Sphingomyelin, which was not hydrolysed, was taken as an internal standard for phospholipid phosphorus assay.
Fatty acids were analysed as the methyl esters by g.l.c. on a Girdel 30 chromatograph. The temperature of the CP Wax capillary column was 210°C. Ethanolamine-and choline-containing glycerophospholipids were isolated by t.l.c., then subjected separately to the phospholipase A1 and HCl hydrolysis. The various spots were scraped off the plate and the lipids treated and analysed the same day. The fatty acid composition at position 2 of the ether phospholipids was obtained by mild alkaline hydrolysis and BF3-catalysed methylation from alkylacyl-GPE and from HCl-hydrolysed acyl-GPE. Fatty acids at position 2 of the diacyl species were calculated by multiplying by 2 the percentage of the methyl esters obtained in mixing the phospholipase Al-hydrolysed acyl-GPE and the fatty acid spot.
Results and discussion
Lipid phosphorus was estimated to be 230+46nmol/109 rat platelets. The major phospholipid species were GPC and GPE. Thus GPE appeared to be somewhat higher than in human platelets (22.9%; Lagarde et al., 1982) but was close to that in rabbit platelets (32.5%; Andreoli, 1968) . Table 1 shows the distribution of radioactivity in the phospholipids upon reincubation of [14C]-arachidonate-labelled platelets. At time 0, radioactivity in GPC was 3-4 times higher than in GPE. Upon reincubation, the radioactivity in GPE gradually increased with time whereas that in GPC concomitantly decreased. The radioactivity recovered in the neutral lipid fraction was essentially incorporated into triacylglycerols and also decreased to some extent. The small increase in GPS labelling was not significant. The lack of change in GPI disagrees with the arachidonate transfer observed form GPC to GPI when platelets were incubated with 1-acyl-2-[ 14C]arachidonyl-GPCloaded high-density lipoprotein (Bereziat et al., 1978) . Thus there was a redistribution of [14C]-arachidonate between phospholipids, essentially from GPC to GPE. Our assays on rat platelet homogenates (Colard et al., 1984) have shown that an arachidonate transfer could be induced by a number of lysoderivatives, including 2-lysoGPC, 2-lysoGPE and 2-lysoGPS. When lysoGPE and -GPS were the acceptors, arachidonate came from GPC and when lysoGPC was the acceptor, the phospholipid donor was GPI. However, in whole rat platelet, as in rabbit macrophages (Sugiura et al., 1984) , no transfer from GPI or GPE occurred. The arachidonate exchange was essentially from GPC to GPE.
To investigate the role of diacyl and ether phospholipids in this arachidonate transfer, we hydrolysed the diacyl phospholipids by pancreatic phospholipase A1 and the alkenyl phospholipids by HCI fumes in order to separate alkyl, alkenyl and diacyl compounds. The ether and diacyl composition of rat platelet choline-and ethanolamine-containing phospholipids (Table 2) was quite different from that of human (Mueller et al., 1983) and rabbit (Sugiura et al., 1983) platelets. Alkenylacyl-GPC was not detected in rat platelets (against 9% and 3% in human and rabbit) and considerable amounts of alkylacyl compounds were found in rat platelet GPE (29%, against 3% and 2% (Sugiura et al., 1983; Mueller et al., 1983) , except for a higher archidonate content in alkylacyl-GPE in rat platelets than in human platelets. In any case, the amount of this phospholipid is very low in human platelets.
As shown in Fig. 1 , the ethanolamine-as well as choline-containing ether phospholipids were poorly labelled at the start of the reincubation and the radioactivity was essentially recovered in diacyl compounds. As a function of time, the labelling of alkylacyl-GPC and -GPE and of alkenylacyl-GPE markedly increased, concomitantly with a decrease of diacyl-GPC labelling. A small increase of diacyl-GPE was also observed. These changes occurred in 5-6h, and then labelling was constant.
In extrapolating the curves of [ 14C]arachidonate increases in the ether phospholipids, one can observe that the intersection with the abscissa is at about 60min before the start of reincubation. This period approximately corresponds to the time necessary for the platelet labelling and washing manipulation. This suggests that free [14C]-arachidonate incorporation via the Lands pathway (Hill & Lands, 1968) occurs only in the diacyl species and that the ether phospholipid labelling is achieved by exchange from GPC, this exchange beginning as soon as [14C] arachidonate is acylated into diacyl-GPC. The absence of ether phospholipid acylation from free arachidonate agrees with the much lower acyltransferase activities to alkenyl-GPE and to alkyl-GPC than to acyl lysoderivatives demonstrated in several tissues (Waku & Nakazawa, 1970; Wykle et al., 1973; Natarajan & Sastry, 1973) .
If this assumption is true, we can consider that the radioactivity recovered in the ether phospholipids at the start of reincubation was primarily incorporated into diacyl-GPC. This would increase the diacyl-GPC specific radioactivity related to phosphorus content (Table 3) If we consider the specific radioactivities related to arachidonyl content in each phospholipid class (Table 3) , we observe that free arachidonate incorporation rates into the GPE and GPC diacyl species were different and consequently not related to the arachidonyl content. The specific radioactivity of arachidonate in diacyl-GPC was 3500d.p.m./nmol at the start of reincubation and arachidonate transfer to ether phospholipids was linear, allowing estimation of transfer rates. Arachidonate transfer rates are 2nmol/h per 109 platelets from diacyl-GPC and 1, 0.6 and 0.45nmol/h per 109 platelets respectively into alkenylacyl-GPE, alkylacyl-GPE and alkylacyl-GPC. Since arachidonyl transfer from diacyl-GPC is linear up to 5h, when equilibrium was reached, 10nmol of arachidonate, relative to a content of 21nmol in diacyl-GPC, have been exchanged.
It is obvious from these data that the pronounced differences between arachidonate specific radioactivities in the various phospholipids observed at the start of reincubation tended to decrease upon reincubation up to an equilibrium state. However, alkylacyl-GPC reached this equilibrium more rapidly than the other ether phospholipids. First, alkylacyl-GPC specific radioactivity was already higher than ether GPE specific radioactivities at the start of reincubation. This suggests that an arachidonyl transfer, more rapid to alkylacyl-GPC than to ether GPE, has occurred during arachidonic acid incorporation and washing of platelets. Second, the increase of alkylacyl-GPC specific radioactivity was almost complete after 2 h reincubation, in contrast with the ethers and diacyl-GPE which increased linearly up to 5 h. So it appears that arachidonic acid turnover by this exchange pathway was more rapid in alkylacyl-GPC than in the other phospholipids. This result agree with the striking selectivity for arachidonate observed by Chilton et al. (1983) in the acylation of deacetylated PAF-acether by human neutrophils.
We (Colard et al., 1984) have found that CoA was a required factor in rat platelet homogenates for exchange of arachidonate from GPC to acyllysoGPE, whereas in human platelet homogenates, Kramer & Deykin (1983) observed a CoAindependent arachidonate transfer from GPC to alkenyl-lysoGPE. Perhaps different transacylation mechanisms, CoA-dependent and -independent, are involved in the specific transfer of arachidonate to the various alkyl, alkenyl and acyl compounds. In any case, lyso compounds were necessary for arachidonyl exchange between phospholipids in rat (Colard et al., 1984) as in human (Kramer & Deykin, 1983 ) platelet homogenates. So this exchange is likely to be regulated by the production of lysoderivatives through a phospholipase A2. It could explain the specific acylation by arachidonate of added l-alkyl-lysoGPC (lysoPAF) as well as l-acyl-lysoGPC and PAF-acether, which is rapidly deacetylated, into lysoPAF, observed in human neutrophils (Chilton et al., 1983 
